当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第22期
编号:13175388
多西他赛联合顺铂同步放化疗治疗局部晚期食管癌的疗效分析(3)
http://www.100md.com 2012年11月15日 《中国医药科学》 2012年第22期
     [参考文献]

    [1] 邹小农.食管癌流行病学[J].中华肿瘤防治杂志,2006,13(18):1-4.

    [2] Ilson DH.Esophageal cancer:New developments in systemic therapy[J].Cancer Treat Rev,2003,29(6):525.

    [3] 张效公.食管贲门外科学[M].北京:协和医科大学出版社,2005:353.

    [4] Reed CE.Surgical management of Esophageal carcinoma [J].Oncologist,1999,4(2):95-105.

    [5] Eisenhauer EA,Therasse P,Bogaerts J,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J].Eur J Cancer, 2009, 45(2):228-247.

    [6] Minsky BD,Pajak TF,Ginsberg RJ,et al.INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy[J].J Clin Oncol,2002,20(5):1167-1174.

    [7] Wong R,Malthaner R.Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus [J].Cochrane Database Syst Rev,2006,25(1):CD002092.

    [8] Sato Y,Takayama T,Sagawa T,et al.A phaseⅠ/Ⅱstudy of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer[J].Cancer Chemother Pharmacol,2006,58(5):570-576.

    [9] Schull B,Kornek GV,Schmid K,et al.Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer[J].Oncology, 2003, 65(3):211-217.

    (收稿日期:2012-09-11), http://www.100md.com(张歌萌 韩良辅 张双燕 薛莹)
上一页1 2 3